For our partners

Possibility to engineer customizable dose and release kinetics based on the therapeutic need as the technology enables tailored sustained release from minutes to hours and a wide API loading range.

Possibility of an enhanced customer acceptance and experience as the formulation has GRAS excipients, is palatable, non-intrusive, and a convenient form factor allowing self-dosing, leading to improved compliance.

Ability to reengineer the release kinetics and dosage with ease if regulatory and market conditions enable the pharmaceutical to move from Rx to OTC.

Confidence working with a team of professionals with decades of experience in the Pharma Biotech sector and in a technology that has been successfully commercialized for the oral care market for over a decade .